Sharmila Mallya

1.1k total citations
20 papers, 656 citations indexed

About

Sharmila Mallya is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Sharmila Mallya has authored 20 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Hematology and 7 papers in Genetics. Recurrent topics in Sharmila Mallya's work include PI3K/AKT/mTOR signaling in cancer (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Sharmila Mallya is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (9 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Chronic Myeloid Leukemia Treatments (7 papers). Sharmila Mallya collaborates with scholars based in United States, Singapore and Croatia. Sharmila Mallya's co-authors include Lomon So, Matthew R. Janes, Marina Konopleva, Pingda Ren, Jose J. Limon, Michael Martin, Michelle M. Lilly, Christian Rommel, Raymond J. Lim and S. Tiong Ong and has published in prestigious journals such as Nature Medicine, Blood and The Journal of Immunology.

In The Last Decade

Sharmila Mallya

20 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharmila Mallya United States 12 495 138 133 108 88 20 656
Fiona C. Brown Australia 13 470 0.9× 260 1.9× 146 1.1× 99 0.9× 143 1.6× 27 697
Laure Vincent France 17 439 0.9× 353 2.6× 66 0.5× 136 1.3× 179 2.0× 58 802
Nadja Kopp United States 9 388 0.8× 180 1.3× 64 0.5× 90 0.8× 163 1.9× 21 643
Nicolas Bonadies Switzerland 14 423 0.9× 264 1.9× 120 0.9× 121 1.1× 60 0.7× 39 723
Soumen Chakraborty India 13 434 0.9× 197 1.4× 88 0.7× 60 0.6× 80 0.9× 27 635
Krista M. Heinonen Canada 14 535 1.1× 96 0.7× 446 3.4× 27 0.3× 125 1.4× 26 863
Parvathi Ranganathan United States 14 538 1.1× 230 1.7× 156 1.2× 69 0.6× 107 1.2× 37 764
Enrico Milan Italy 11 456 0.9× 131 0.9× 192 1.4× 48 0.4× 101 1.1× 16 784
Eric Laille United States 16 703 1.4× 631 4.6× 67 0.5× 165 1.5× 208 2.4× 38 1.1k
Shaina N. Porter United States 14 597 1.2× 108 0.8× 181 1.4× 60 0.6× 93 1.1× 21 758

Countries citing papers authored by Sharmila Mallya

Since Specialization
Citations

This map shows the geographic impact of Sharmila Mallya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharmila Mallya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharmila Mallya more than expected).

Fields of papers citing papers by Sharmila Mallya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharmila Mallya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharmila Mallya. The network helps show where Sharmila Mallya may publish in the future.

Co-authorship network of co-authors of Sharmila Mallya

This figure shows the co-authorship network connecting the top 25 collaborators of Sharmila Mallya. A scholar is included among the top collaborators of Sharmila Mallya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharmila Mallya. Sharmila Mallya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pandori, William, et al.. (2024). Role for Caspase-8 in the Release of IL-1β and Active Caspase-1 from Viable Human Monocytes during Toxoplasma gondii Infection. The Journal of Immunology. 212(7). 1161–1171. 4 indexed citations
2.
Buono, Roberta, Shannon M. Matulis, Vikas A. Gupta, et al.. (2023). Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 Inhibitors. Cancer Research Communications. 3(12). 2497–2509. 3 indexed citations
3.
Mallya, Sharmila, et al.. (2023). Multiomic and spatial immunophenotyping reveals a prominent Runx3+ resident T cell population in the healthy human breast. The Journal of Immunology. 210(Supplement_1). 63.12–63.12. 1 indexed citations
4.
Vo, Thanh‐Trang, et al.. (2021). Targeting eIF4F translation complex sensitizes B-ALL cells to tyrosine kinase inhibition. Scientific Reports. 11(1). 21689–21689. 2 indexed citations
5.
Chiu, Honyin, et al.. (2021). Reduced eIF4E function impairs B-cell leukemia without altering normal B-lymphocyte function. iScience. 24(7). 102748–102748. 7 indexed citations
6.
Lee, Bianca J., Sharmila Mallya, Nuntana Dinglasan, et al.. (2021). Efficacy of a Novel Bi-Steric mTORC1 Inhibitor in Models of B-Cell Acute Lymphoblastic Leukemia. Frontiers in Oncology. 11. 673213–673213. 11 indexed citations
7.
Lima, Tatiane S., Sharmila Mallya, Allen Jankeel, Ilhem Messaoudi, & Melissa B. Lodoen. (2021). Toxoplasma gondii Extends the Life Span of Infected Human Neutrophils by Inducing Cytosolic PCNA and Blocking Activation of Apoptotic Caspases. mBio. 12(1). 11 indexed citations
8.
Walters, Beth, Roberta Buono, Sharmila Mallya, et al.. (2020). Targeting eIF4F translation initiation complex with SBI-756 sensitises B lymphoma cells to venetoclax. British Journal of Cancer. 124(6). 1098–1109. 14 indexed citations
9.
Mallya, Sharmila, et al.. (2020). Toxoplasma gondii Dysregulates Barrier Function and Mechanotransduction Signaling in Human Endothelial Cells. mSphere. 5(1). 17 indexed citations
10.
Pandori, William, et al.. (2019). Toxoplasma gondii activates a Syk-CARD9-NF-κB signaling axis and gasdermin D-independent release of IL-1β during infection of primary human monocytes. PLoS Pathogens. 15(8). e1007923–e1007923. 51 indexed citations
11.
Mallya, Sharmila, et al.. (2018). mTOR inhibition enhances efficacy of dasatinib in ABL-rearranged Ph-like B-ALL. Oncotarget. 9(5). 6562–6571. 16 indexed citations
12.
Nguyen, Duc, William Pandori, Sharmila Mallya, et al.. (2017). mTORC1 Inhibition Induces Resistance to Methotrexate and 6-Mercaptopurine in Ph+ and Ph-like B-ALL. Molecular Cancer Therapeutics. 16(9). 1942–1953. 11 indexed citations
13.
Chiu, Honyin, Sharmila Mallya, David G. Winkler, et al.. (2017). The Selective Phosphoinoside-3-Kinase p110δ Inhibitor IPI-3063 Potently Suppresses B Cell Survival, Proliferation, and Differentiation. Frontiers in Immunology. 8. 747–747. 17 indexed citations
14.
Vo, Thanh‐Trang, Sharmila Mallya, Qi Zhang, et al.. (2016). mTOR Kinase Inhibitors Enhance Efficacy of TKIs in Preclinical Models of Ph-like B-ALL. Blood. 128(22). 2763–2763. 3 indexed citations
15.
So, Lomon, Jong‐Dae Lee, Sharmila Mallya, et al.. (2016). The 4E-BP–eIF4E axis promotes rapamycin-sensitive growth and proliferation in lymphocytes. Science Signaling. 9(430). ra57–ra57. 54 indexed citations
16.
Yea, Sung Su, Lomon So, Sharmila Mallya, et al.. (2014). Effects of Novel Isoform-Selective Phosphoinositide 3-Kinase Inhibitors on Natural Killer Cell Function. PLoS ONE. 9(6). e99486–e99486. 11 indexed citations
17.
Nguyen, Duc, Sharmila Mallya, Sarah Tang, et al.. (2014). mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill B-cell acute lymphoblastic leukemia cells. Oncotarget. 6(4). 2088–2100. 29 indexed citations
18.
Mallya, Sharmila, et al.. (2014). Resistance to mTOR Kinase Inhibitors in Lymphoma Cells Lacking 4EBP1. PLoS ONE. 9(2). e88865–e88865. 33 indexed citations
19.
Janes, Matthew R., Sharmila Mallya, Jose J. Limon, et al.. (2012). Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia. Leukemia. 27(3). 586–594. 85 indexed citations
20.
Janes, Matthew R., Jose J. Limon, Lomon So, et al.. (2010). Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor. Nature Medicine. 16(2). 205–213. 276 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fiona C. Brown Breakdown of academic impact, for papers by Laure Vincent Breakdown of academic impact, for papers by Nadja Kopp Breakdown of academic impact, for papers by Nicolas Bonadies Breakdown of academic impact, for papers by Soumen Chakraborty Breakdown of academic impact, for papers by Krista M. Heinonen Breakdown of academic impact, for papers by Parvathi Ranganathan Breakdown of academic impact, for papers by Enrico Milan Breakdown of academic impact, for papers by Eric Laille Breakdown of academic impact, for papers by Shaina N. Porter
Rankless by CCL
2026